Advancing photocytotoxicity evaluation of nitric oxide derivative-ruthenium complex in 3D biofabricated breast cancer models
Open Access
- 11 June 2026
- journal article
- Published by Elsevier in Materials Today Bio
- Vol. 39, 103348
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (R01EB034566)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2020/03367-6)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2023/11239-6)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/19744-4)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2026/01389-9)
This publication has 45 references indexed in Scilit:
- Synergistic effect of NO and reactive oxygen species as a new approach in PDT: Photobiological and biochemical studies involving phthalocyanine-ruthenium complexes as new photosensitizerJournal of Photochemistry and Photobiology A: Chemistry, 2025
- Patient-derived organoids in precision cancer medicineMed, 2024
- Chemical approach for obtaining a porphyrin bonded to nitro-ruthenium derivative as a promising photosensitizer for enhancing light irradiation therapyInorganic Chemistry Communications, 2024
- Could 3D models of cancer enhance drug screening?Biomaterials, 2020
- Photobiomodulation combined with photodynamic therapy using ruthenium phthalocyanine complexes in A375 melanoma cells: Effects of nitric oxide generation and ATP productionJournal of Photochemistry and Photobiology B: Biology, 2019
- Caspases in Cell Death, Inflammation, and DiseaseImmunity, 2019
- 3D bioprinting for drug discovery and development in pharmaceuticsActa Biomaterialia, 2017
- Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cellsFree Radical Biology and Medicine, 2017
- Application areas of 3D bioprintingDrug Discovery Today, 2016
- Role of interleukin-6 in cancer progression and therapeutic resistanceTumor Biology, 2016